NCT00648258View on ClinicalTrials.gov

A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

April 30, 2004

Conditions
Osteoarthritis
Interventions
DRUG

valdecoxib

valdecoxib 10 mg tablet by mouth once daily for 6 weeks

DRUG

naproxen

naproxen 500 mg capsule by mouth twice daily for 6 weeks

Trial Locations (4)

Unknown

Pfizer Investigational Site, Kweishan

Pfizer Investigational Site, Kaohsiung City

Pfizer Investigational Site, Taichung

Pfizer Investigational Site, Taipei

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00648258 - A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan | Biotech Hunter | Biotech Hunter